The Effect of Lubricants on Viability of Bacillus Calmette-Guerin for Intravesical Immunotherapy Against Bladder Carcinoma
Authors:
- A. BohleABA. Bohle
- S. Rusch-GerdesSRS. Rusch-Gerdes
- A. J. UlmerAUA. J. Ulmer
- H. BraaschHBH. Braasch
- D. JochamDJD. Jocham
- 1 June 1996
- journal article
- Published by Wolters Kluwer Health in Journal of Urology
- p. 1892-1896
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- The induction of bacillus-Calmette-Gu rin-activated killer cells requires the presence of monocytes and T-helper type-1 cellsCancer Immunology, Immunotherapy, 1995
- Dissecting the Immunobiological Effects of Bacillus Calmette-Guérin (BCG) In Vitro: Evidence of a Distinct BCG-Activated Killer (BAK) Cell PhenomenonJournal of Urology, 1993
- Intravesical Evans Strain BCG Therapy: Quantitative Immunohistochemical Analysis of the Immune Response within the Bladder WallJournal of Urology, 1992
- Bacillus Calmette-Guerin Therapy for Superficial Bladder Cancer: A 10-Year FollowupJournal of Urology, 1992
- A Randomized Trial of Intravesical Doxorubicin and Immunotherapy with Bacille Calmette–Guérin for Transitional-Cell Carcinoma of the BladderNew England Journal of Medicine, 1991
- Effects of Local Bacillus Calmette-Guerin Therapy in Patients with Bladder Carcinoma on Immunocompetent Cells of the Bladder WallJournal of Urology, 1990
- Elevations of Cytokines Interleukin-1, Interleukin-2 and Tumor Necrosis Factor in the Urine of Patients after Intravesical Bacillus Calmette-Guerin ImmunotherapyJournal of Urology, 1990
- HLA—DR Expression by High Grade Superficial Bladder Cancer Treated with BCGBritish Journal of Urology, 1989
- Requirement of a Thymus Dependent Immune Response for Bcg-mediated Antitumor ActivityJournal of Urology, 1987
- Intravesical Bacillus Calmette-Guerin Therapy for Superficial Bladder Cancer: Effect of Bacillus Calmette-Guerin Viability on Treatment ResultsJournal of Urology, 1985